IPP Bureau
Time to move from ‘Volume’ to ‘Value’ leadership to capture global market, says Mandaviya
By IPP Bureau - July 03, 2022
Govt committed to supporting pharma companies with industry-friendly policies
Maria Soler Nunez appointed Head, Group Operations of Lonza
By IPP Bureau - July 02, 2022
Prior to this, Maria held multiple roles at Novartis including Head of Global Manufacturing Functions, and Global Head of Manufacturing, Science & Technology
Lonza to invest 500 mn in commercial drug product fill & finish facility
By IPP Bureau - July 02, 2022
The investment will enable the company to provide customers with a complete and integrated end-to-end solution
UK Parliament honours All India Institute of Ayurveda’s Director Dr Tanuja Nesari with Ayurveda Ratna Award
By IPP Bureau - July 02, 2022
The award was presented to her during a virtual ceremony on the occasion of 8th International Day of Yoga on 21st June 2022.
Ascentage Pharma gets IND clearance by the US FDA for novel EED Inhibitor APG-5918
By IPP Bureau - July 02, 2022
This multicenter, open-label Phase I study is designed to assess the safety and tolerability
Ardelyx gets into $20 million financing agreement with HealthCare Royalty Partners
By IPP Bureau - July 02, 2022
HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA in the United States
NITI Aayog releases a compendium of Ayush-based practices
By IPP Bureau - July 02, 2022
The compendium was released by Suman Bery, Vice-Chairman, NITI Aayog and Dr. Munjpara Mahendrabhai Kalubhai, Minister of State for Ayush and WCD.
Biosynth Carbosynth expands peptide offering with acquisition of Pepscan
By IPP Bureau - July 01, 2022
Addition of Pepscan with its peptide discovery, lead optimization and GMP manufacturing capabilities provides end-to-end offering to Biosynth Carbosynth’s peptide customers.
Jubilant HollisterStier announces CAD 100 mn for Montreal facility
By IPP Bureau - July 01, 2022
The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million
Lupin receives approval from USFDA for Paliperidone extended-release tablets
By IPP Bureau - July 01, 2022
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 152 million in the U.S
Zydus receives final approval from USFDA for Lacosamide injection
By IPP Bureau - July 01, 2022
Lacosamide Injection is used to treat partial-onset seizures.
H Clinical adds commercial home health capabilities for pharma industry
By IPP Bureau - July 01, 2022
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
Akebia Therapeutics regaining rights to Vadadustat in the US, Europe and China
By IPP Bureau - July 01, 2022
Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia
Biologicals have emerged as a therapy of choice where traditional chemical drugs fail: Dr Bharati Pravin Pawar
By IPP Bureau - July 01, 2022
National Institute of Biologicals should undertake the testing of more biologicals and also extend its testing expertise in helping other countries
JB Pharma acquires 4 paediatric brands from Dr Reddy’s Laboratories
By IPP Bureau - July 01, 2022
The total covered market size of four brands – Z&D, Pediclory, Pecef & Ezinapi combined is Rs 1800 crores
